Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Subscriber Content

Shanghai Starts New Antibody Institute; Names US Researcher as Director

publication date: Oct 15, 2012

Shanghai has established an institute for advanced immunochemical studies, sponsored by Shanghai Tech University and the Shanghai Advanced Research Institute under the Chinese Academy of Sciences. Its goal is to advance antibody drug R&D. Richard Lerner, MD, a research chemist who recently stepped down after twenty years as head of The Scripps Research Institute, was named the institute’s first director. Lerner will lead a team of experts from the US, Europe and China. More details....

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.If you're not a subscriber why not subscribe today?